James A. Breckenridge
Founder at Med Opportunity Partners LLC
Profile
Mr. James A.
Breckenridge is Partner & Co-Founder at Med Opportunity Partners LLC.
Prior to the formation of the firm, Mr. Breckenridge was Partner at UBS Capital Americas.
He joined UBS Capital Americas in 1993 he has overseen and participated in private equity transactions across a wide variety of industries including Healthcare, Medical Devices & Products, Performance Chemicals and General Industrial.
He is currently a generalist and serves on the Board of Directors of Avail Medical.
Prior to joining UBS Capital Americas Mr. Breckenridge worked in the Equity research department of Kidder, Peabody & Company Inc. following food, beverage and tobacco industries.
Mr. Breckenridge graduated from Colgate University and received his MBA from Columbia University Graduate School of Business.
He serves as a director of Avail Medical Products, Inc.
James A. Breckenridge active positions
Companies | Position | Start |
---|---|---|
Med Opportunity Partners LLC
Med Opportunity Partners LLC Investment ManagersFinance Med Opportunity Partners LLC is a private equity firm founded in 2006 by Robert Vaters, Vicente Trelles and James Breckenridge headquarter is in Connecticut United States. | Founder | 2010-12-10 |
Pfanstiehl, Inc.
Pfanstiehl, Inc. Pharmaceuticals: MajorHealth Technology Pfanstiehl, Inc. develops endotoxin injectable formulation and pharmaceutical ingredients. The firm specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company was founded by Carl A. Pfanstiehl in 1919 and is headquartered in Waukegan, IL. | President | 2016-12-31 |
Former positions of James A. Breckenridge
Companies | Position | End |
---|---|---|
UBS Capital Americas LLC
UBS Capital Americas LLC Investment ManagersFinance Spun out of UBS AG (NYSE: UBS) in 2000, UBS Capital Americas LLC is a private equity firm based in New York City | Private Equity Analyst | 2006-12-30 |
Kidder, Peabody & Co., Inc.
Kidder, Peabody & Co., Inc. Investment Banks/BrokersFinance Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander. | Corporate Officer/Principal | - |
Training of James A. Breckenridge
Colgate University | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
UBS Capital Americas LLC
UBS Capital Americas LLC Investment ManagersFinance Spun out of UBS AG (NYSE: UBS) in 2000, UBS Capital Americas LLC is a private equity firm based in New York City | Finance |
Med Opportunity Partners LLC
Med Opportunity Partners LLC Investment ManagersFinance Med Opportunity Partners LLC is a private equity firm founded in 2006 by Robert Vaters, Vicente Trelles and James Breckenridge headquarter is in Connecticut United States. | Finance |
Kidder, Peabody & Co., Inc.
Kidder, Peabody & Co., Inc. Investment Banks/BrokersFinance Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander. | Finance |
Pfanstiehl, Inc.
Pfanstiehl, Inc. Pharmaceuticals: MajorHealth Technology Pfanstiehl, Inc. develops endotoxin injectable formulation and pharmaceutical ingredients. The firm specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company was founded by Carl A. Pfanstiehl in 1919 and is headquartered in Waukegan, IL. | Health Technology |
- Stock Market
- Insiders
- James A. Breckenridge